Literature DB >> 12694373

Effects of ageing and long-term hormone replacement on cholinergic neurones in the medial septum and nucleus basalis magnocellularis of ovariectomized rats.

R B Gibbs1.   

Abstract

Ovariectomized aged rats, some of which received long-term hormone replacement with oestrogen or oestrogen plus progesterone, were evaluated for the number and size of basal forebrain cholinergic neurones, as well as relative levels of choline acetyltransferase (ChAT) and trkA mRNA, in order to determine whether effects on basal forebrain cholinergic cell survival and function correspond with differences in cognitive performance previously described. The results show that ageing combined with long-term loss of ovarian function produced substantial reductions in the levels of ChAT and trkA mRNA in the medial septum and nucleus basalis magnocellularis, relative to much younger ovariectomized controls. In contrast, no significant effects on the number or size of the cholinergic cells were detected, indicating that loss of ovarian function does not cause a loss of cholinergic neurones with age. Long-term hormone replacement had no apparent effect on the number of ChAT-positive neurones detected, and did not prevent the reductions in ChAT and trkA mRNA associated with ovariectomy and ageing. Collectively, the data suggest that ageing combined with long-term loss of ovarian function has a severe negative impact on basal forebrain cholinergic function, but not on cholinergic cell survival per se.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12694373     DOI: 10.1046/j.1365-2826.2003.01012.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  15 in total

1.  Progesterone enhances learning and memory of aged wildtype and progestin receptor knockout mice.

Authors:  Cheryl A Frye; Alicia A Walf
Journal:  Neurosci Lett       Date:  2010-02-01       Impact factor: 3.046

Review 2.  Minireview: translational animal models of human menopause: challenges and emerging opportunities.

Authors:  Roberta Diaz Brinton
Journal:  Endocrinology       Date:  2012-07-09       Impact factor: 4.736

3.  The endocrine-brain-aging triad where many paths meet: female reproductive hormone changes at midlife and their influence on circuits important for learning and memory.

Authors:  Stephanie V Koebele; Heather A Bimonte-Nelson
Journal:  Exp Gerontol       Date:  2016-12-13       Impact factor: 4.032

4.  Age-related changes in neuroprotection: is estrogen pro-inflammatory for the reproductive senescent brain?

Authors:  Farida Sohrabji; Shameena Bake
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

Review 5.  Neuroprotective actions of estradiol and novel estrogen analogs in ischemia: translational implications.

Authors:  Anne M Etgen; Teresa Jover-Mengual; R Suzanne Zukin
Journal:  Front Neuroendocrinol       Date:  2010-12-14       Impact factor: 8.606

Review 6.  GPR30 is positioned to mediate estrogen effects on basal forebrain cholinergic neurons and cognitive performance.

Authors:  R Hammond; R B Gibbs
Journal:  Brain Res       Date:  2010-12-05       Impact factor: 3.252

Review 7.  Neuroprotective action of acute estrogens: animal models of brain ischemia and clinical implications.

Authors:  Tomoko Inagaki; Anne M Etgen
Journal:  Steroids       Date:  2013-02-04       Impact factor: 2.668

8.  Progesterone to ovariectomized mice enhances cognitive performance in the spontaneous alternation, object recognition, but not placement, water maze, and contextual and cued conditioned fear tasks.

Authors:  Cheryl A Frye; Alicia A Walf
Journal:  Neurobiol Learn Mem       Date:  2008-05-01       Impact factor: 2.877

Review 9.  Estrogen therapy and cognition: a review of the cholinergic hypothesis.

Authors:  Robert B Gibbs
Journal:  Endocr Rev       Date:  2009-12-17       Impact factor: 19.871

10.  Progesterone enhances performance of aged mice in cortical or hippocampal tasks.

Authors:  Cheryl A Frye; Alicia A Walf
Journal:  Neurosci Lett       Date:  2008-04-07       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.